Baxter Holding B.V.

Φαρμακευτικά σκευάσματα

Η εταιρεία έχει λάβει από τις αρμόδιες αρχές άδεια κυκλοφορίας για τα παρακάτω φαρμακευτικά σκευάσματα:

Κωδικός	Όνομα	Κ	Ν.Τ.	Χ.Τ.	Λ.Τ.	Κάτοχος άδειας
225810101	CAELYX PEGYLATED LIPOSOMAL C/S.SOL.IN 2MG/ML 1VIALX10ML		269,38	299,61	355,69	Baxter Holding B.V.
322900101	DEXMEDETOMIDINE/BAXTER C/S.SOL.IN 100MCG/ML BT X 5 VIALS X 2ML		43,55	50,06	63,67	Baxter Holding B.V.
338470101	ERIBULIN BAXTER INJ.SOL 0,44MG/ML BT X 1 VIAL X 2ML		160,26	184,22	222,61	Baxter Holding B.V.
323680101	LINEZOLID/BAXTER SOL.INF 2MG/ML BTx5 BAGS {PolyOlefin (PVC-free)} x 300ml		89,75	103,16	126,84	Baxter Holding B.V.
333120101	PEMETREXED BAXTER PD.C.SO.IN 100MG/VIAL BT X 1 VIAL		86,00	98,86	125,75	Baxter Holding B.V.
333120201	PEMETREXED BAXTER PD.C.SO.IN 500MG/VIAL BT X 1 VIAL		430,01	478,26	552,58	Baxter Holding B.V.
324140106	PROPOFOL/BAXTER INJ.EM.IN 10MG/ML BTx1x100 ML (colourless glass vial-type II) (colourless glass vial-type II)		5,53	6,36	8,76	Baxter Holding B.V.
324140104	PROPOFOL/BAXTER INJ.EM.IN 10MG/ML BTx1x50 ML (colourless glass vial-type II) (colourless glass vial-type II)		7,27	8,36	11,52	Baxter Holding B.V.
324140102	PROPOFOL/BAXTER INJ.EM.IN 10MG/ML BTx5x20 ML (colourless glass vial-type II)		3,65	4,20	5,79	Baxter Holding B.V.
291490106	SPIVA INJ.EM.IN 10MG/ML BTx1x100 ML (colourless glass vial-type II) (colourless glass vial-type II)		3,83	4,41	6,07	Baxter Holding B.V.
291490104	SPIVA INJ.EM.IN 10MG/ML BTx1x50 ML (colourless glass vial-type II) (colourless glass vial-type II)		2,23	2,56	3,53	Baxter Holding B.V.
291490102	SPIVA INJ.EM.IN 10MG/ML BTx5x20 ML (colourless glass vial-type II)		3,82	4,40	6,06	Baxter Holding B.V.
330520101	SUGAMMADEX/BAXTER INJ.SOL 100MG/ML BT X 10 VIALS X 2ML		412,30	458,57	529,83	Baxter Holding B.V.
330520102	SUGAMMADEX/BAXTER INJ.SOL 100MG/ML BT X 10 VIALS X 5ML		1.051,79	1.169,81	1.302,00	Baxter Holding B.V.